Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China flag China · Delayed Price · Currency is CNY
64.30
+1.17 (1.85%)
At close: Jan 23, 2026

Hangzhou AGS MedTech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
5,1904,8107,223---
Upgrade
Market Cap Growth
4.99%-33.41%----
Upgrade
Enterprise Value
3,4522,7235,252---
Upgrade
Last Close Price
64.3058.4385.62---
Upgrade
PE Ratio
19.0816.3933.25---
Upgrade
Forward PE
16.0315.01----
Upgrade
PS Ratio
7.767.5614.20---
Upgrade
PB Ratio
2.092.013.27---
Upgrade
P/TBV Ratio
2.102.023.30---
Upgrade
P/FCF Ratio
34.7018.0742.52---
Upgrade
P/OCF Ratio
23.7215.2332.62---
Upgrade
EV/Sales Ratio
5.164.2810.32---
Upgrade
EV/EBITDA Ratio
12.649.3923.31---
Upgrade
EV/EBIT Ratio
13.129.6524.01---
Upgrade
EV/FCF Ratio
23.0810.2330.92---
Upgrade
Debt / Equity Ratio
0.000.0000.000.01-
Upgrade
Debt / EBITDA Ratio
0.010.010.000.010.02-
Upgrade
Debt / FCF Ratio
0.020.010.000.020.02-
Upgrade
Asset Turnover
0.270.260.360.911.010.72
Upgrade
Inventory Turnover
3.223.513.513.043.623.31
Upgrade
Quick Ratio
18.2212.9117.373.183.193.90
Upgrade
Current Ratio
18.9313.3417.783.653.814.43
Upgrade
Return on Equity (ROE)
11.41%12.74%16.78%44.40%42.94%23.30%
Upgrade
Return on Assets (ROA)
6.57%7.22%9.75%23.02%24.30%12.33%
Upgrade
Return on Invested Capital (ROIC)
33.12%61.09%131.83%143.69%155.62%89.30%
Upgrade
Return on Capital Employed (ROCE)
10.50%11.70%9.90%39.30%42.90%21.80%
Upgrade
Earnings Yield
5.26%6.10%3.01%---
Upgrade
FCF Yield
2.88%5.54%2.35%---
Upgrade
Dividend Yield
2.14%2.35%1.21%---
Upgrade
Payout Ratio
40.74%28.40%20.25%24.80%46.80%-
Upgrade
Buyback Yield / Dilution
-0.35%-11.02%-19.46%0.00%-0.10%
Upgrade
Total Shareholder Return
1.82%-8.67%-18.25%--0.10%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.